These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
338 related items for PubMed ID: 28035924
1. The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial. Carotenuto A, Rea R, Traini E, Fasanaro AM, Ricci G, Manzo V, Amenta F. J Alzheimers Dis; 2017; 56(2):805-815. PubMed ID: 28035924 [Abstract] [Full Text] [Related]
2. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results. Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E. J Neurol Sci; 2012 Nov 15; 322(1-2):96-101. PubMed ID: 22959283 [Abstract] [Full Text] [Related]
3. Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial. Rea R, Carotenuto A, Traini E, Fasanaro AM, Manzo V, Amenta F. J Alzheimers Dis; 2015 Nov 15; 48(2):377-83. PubMed ID: 26402001 [Abstract] [Full Text] [Related]
4. The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: interim results after two years of treatment. Amenta F, Carotenuto A, Fasanaro AM, Rea R, Traini E. J Alzheimers Dis; 2014 Nov 15; 42 Suppl 3():S281-8. PubMed ID: 24898643 [Abstract] [Full Text] [Related]
5. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. Gauthier S, Feldman H, Hecker J, Vellas B, Ames D, Subbiah P, Whalen E, Emir B, Donepezil MSAD Study Investigators Group. Int Psychogeriatr; 2002 Dec 15; 14(4):389-404. PubMed ID: 12670060 [Abstract] [Full Text] [Related]
6. Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders. Cummings JL, McRae T, Zhang R, Donepezil-Sertraline Study Group. Am J Geriatr Psychiatry; 2006 Jul 15; 14(7):605-12. PubMed ID: 16816014 [Abstract] [Full Text] [Related]
7. Association Between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in the Treatment of Depression in Patients with Alzheimer's Disease. Carotenuto A, Fasanaro AM, Manzo V, Amenta F, Traini E. J Alzheimers Dis Rep; 2022 Jul 15; 6(1):235-243. PubMed ID: 35719710 [Abstract] [Full Text] [Related]
8. Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease. Waldemar G, Gauthier S, Jones R, Wilkinson D, Cummings J, Lopez O, Zhang R, Xu Y, Sun Y, Knox S, Richardson S, Mackell J. Int J Geriatr Psychiatry; 2011 Feb 15; 26(2):150-7. PubMed ID: 20597141 [Abstract] [Full Text] [Related]
9. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting. Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E. J Am Geriatr Soc; 2001 Dec 15; 49(12):1590-9. PubMed ID: 11843990 [Abstract] [Full Text] [Related]
10. The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease. Mega MS, Masterman DM, O'Connor SM, Barclay TR, Cummings JL. Arch Neurol; 1999 Nov 15; 56(11):1388-93. PubMed ID: 10555660 [Abstract] [Full Text] [Related]
11. Are cholinesterase inhibitors effective in the management of the behavioral and psychological symptoms of dementia in Alzheimer's disease? A systematic review of randomized, placebo-controlled trials of donepezil, rivastigmine and galantamine. Rodda J, Morgan S, Walker Z. Int Psychogeriatr; 2009 Oct 15; 21(5):813-24. PubMed ID: 19538824 [Abstract] [Full Text] [Related]
12. Effect of ninjin'yoeito, a Kampo (traditional Japanese) medicine, on cognitive impairment and depression in patients with Alzheimer's disease: 2 years of observation. Kudoh C, Arita R, Honda M, Kishi T, Komatsu Y, Asou H, Mimura M. Psychogeriatrics; 2016 Mar 15; 16(2):85-92. PubMed ID: 25918972 [Abstract] [Full Text] [Related]
13. Impact of donepezil hydrochloride on the care burden of family caregivers of patients with Alzheimer's disease. Hashimoto M, Yatabe Y, Kaneda K, Honda K, Ikeda M. Psychogeriatrics; 2009 Dec 15; 9(4):196-203. PubMed ID: 20377821 [Abstract] [Full Text] [Related]
14. Impact of Donepezil and Memantine on Behavioral and Psychological Symptoms of Alzheimer Disease: Six-month Open-label Study. Bago Rožanković P, Rožanković M, Badžak J, Stojić M, Šušak Sporiš I. Cogn Behav Neurol; 2021 Dec 02; 34(4):288-294. PubMed ID: 34851866 [Abstract] [Full Text] [Related]
15. Relationship between dementia severity and behavioural and psychological symptoms in early-onset Alzheimer's disease. Tanaka H, Hashimoto M, Fukuhara R, Ishikawa T, Yatabe Y, Kaneda K, Yuuki S, Honda K, Matsuzaki S, Tsuyuguchi A, Hatada Y, Ikeda M. Psychogeriatrics; 2015 Dec 02; 15(4):242-7. PubMed ID: 25737233 [Abstract] [Full Text] [Related]
16. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial. Cumbo E, Ligori LD. J Alzheimers Dis; 2014 Dec 02; 39(3):477-85. PubMed ID: 24164733 [Abstract] [Full Text] [Related]
17. Increased dosage of donepezil for the management of behavioural and psychological symptoms of dementia in dementia with Lewy bodies. Manabe Y, Ino T, Yamanaka K, Kosaka K. Psychogeriatrics; 2016 May 02; 16(3):202-8. PubMed ID: 26179411 [Abstract] [Full Text] [Related]
18. Volume Analysis of Brain Cognitive Areas in Alzheimer's Disease: Interim 3-Year Results from the ASCOMALVA Trial. Traini E, Carotenuto A, Fasanaro AM, Amenta F. J Alzheimers Dis; 2020 May 02; 76(1):317-329. PubMed ID: 32508323 [Abstract] [Full Text] [Related]
19. Caregiver burden associated with behavioral and psychological symptoms of dementia in elderly people in the local community. Matsumoto N, Ikeda M, Fukuhara R, Shinagawa S, Ishikawa T, Mori T, Toyota Y, Matsumoto T, Adachi H, Hirono N, Tanabe H. Dement Geriatr Cogn Disord; 2007 May 02; 23(4):219-24. PubMed ID: 17299264 [Abstract] [Full Text] [Related]
20. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial. Lee W, Kim M. Medicine (Baltimore); 2024 Jun 14; 103(24):e38067. PubMed ID: 38875437 [Abstract] [Full Text] [Related] Page: [Next] [New Search]